Skip to main content

Vestal Point Capital, LP

Position in BCAX — Bicara Therapeutics Inc.

CIK 1974915 NEW YORK, NY

Position in BCAX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$107,903,250
+$47,736,000 QoQ
Shares Held
5,425,000
+51.7% QoQ
Ownership
8.26%
of shares outstanding
% of Portfolio
3.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BCAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $2,697,459,670 across 67 Biotechnology names. BCAX ranks #6 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BCAX
Bicara Therapeutics Inc.
This page
5,425,000 $107,903,250

All Filings in BCAX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $107,903,250 5,425,000
2025-12-31 $60,167,250 3,575,000
2025-09-30 $80,529,000 5,100,000
2025-06-30 $46,450,000 5,000,000
2025-03-31 $36,079,744 2,768,975
2025-03-31 $36,079,744 2,768,975
2024-12-31 $12,368,200 710,000
2024-09-30 $10,824,750 425,000